HINGE HEALTH INC-A (HNGE) Stock Price, Quote, News and Overview
NYSE:HNGE - New York Stock Exchange, Inc. - US4333131039 - Common Stock - Currency: USD
HNGE Quote, Performance and Key Statistics
NYSE:HNGE (8/8/2025, 10:12:06 AM)
57.895
-2.45 (-4.07%)
The current stock price of HNGE is 57.895 USD. In the past month the price increased by 36.72%.
HNGE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.15 | 81.39B | ||
| CI | THE CIGNA GROUP | 9.73 | 72.99B | ||
| LH | LABCORP HOLDINGS INC | 17.34 | 21.77B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.61 | 19.68B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 13.71 | 14.08B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 95.11 | 12.42B | ||
| HIMS | HIMS & HERS HEALTH INC | 64.85 | 11.61B | ||
| DVA | DAVITA INC | 13.25 | 9.70B | ||
| GH | GUARDANT HEALTH INC | N/A | 6.60B | ||
| CHE | CHEMED CORP | 19.56 | 6.40B | ||
| OPCH | OPTION CARE HEALTH INC | 20.82 | 4.60B | ||
| CRVL | CORVEL CORP | 47.19 | 4.42B |
Related stock screener links
About HNGE
Company Profile
Hinge Health Inc is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in San Francisco, California. The company went IPO on 2025-05-22. Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The firm has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. The company offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
Company Info
HINGE HEALTH INC-A
455 Market Street, Suite 700
San Francisco CALIFORNIA US
Employees: 0
Phone: 14156898429
HINGE HEALTH INC-A / HNGE FAQ
What is the stock price of HINGE HEALTH INC-A today?
The current stock price of HNGE is 57.895 USD. The price decreased by -4.07% in the last trading session.
What is the ticker symbol for HINGE HEALTH INC-A stock?
The exchange symbol of HINGE HEALTH INC-A is HNGE and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is HNGE stock listed?
HNGE stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for HINGE HEALTH INC-A stock?
19 analysts have analysed HNGE and the average price target is 50.83 USD. This implies a price decrease of -12.2% is expected in the next year compared to the current price of 57.895. Check the HINGE HEALTH INC-A stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is HINGE HEALTH INC-A worth?
HINGE HEALTH INC-A (HNGE) has a market capitalization of 4.52B USD. This makes HNGE a Mid Cap stock.
How many employees does HINGE HEALTH INC-A have?
HINGE HEALTH INC-A (HNGE) currently has 0 employees.
What are the support and resistance levels for HINGE HEALTH INC-A (HNGE) stock?
HINGE HEALTH INC-A (HNGE) has a support level at 45.65. Check the full technical report for a detailed analysis of HNGE support and resistance levels.
Is HINGE HEALTH INC-A (HNGE) expected to grow?
The Revenue of HINGE HEALTH INC-A (HNGE) is expected to grow by 33.58% in the next year. Check the estimates tab for more information on the HNGE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy HINGE HEALTH INC-A (HNGE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HNGE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HNGE, evaluating the profitability, health, valuation and growth aspects
- HINGE HEALTH INC-A (HNGE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- HINGE HEALTH INC-A (HNGE) Sales and EPS estimates to see what analysts future expectations are.
- HINGE HEALTH INC-A (HNGE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- HINGE HEALTH INC-A (HNGE) Insider and Institutional Ownership to learn about the owners and their transactions.
- HINGE HEALTH INC-A (HNGE) Stock Chart to make your own analysis
- HINGE HEALTH INC-A (HNGE) Latest news and press-releases to stay up to date.
Does HINGE HEALTH INC-A (HNGE) stock pay dividends?
HNGE does not pay a dividend.
What is the Price/Earnings (PE) ratio of HINGE HEALTH INC-A (HNGE)?
HINGE HEALTH INC-A (HNGE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.15).
What is the Short Interest ratio of HINGE HEALTH INC-A (HNGE) stock?
The outstanding short interest for HINGE HEALTH INC-A (HNGE) is 17.63% of its float. Check the ownership tab for more information on the HNGE short interest.
HNGE Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to HNGE.
HNGE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to HNGE. While HNGE has a great health rating, there are worries on its profitability.
HNGE Financial Highlights
Over the last trailing twelve months HNGE reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS increased by 88.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.67% | ||
| ROE | -2.72% | ||
| Debt/Equity | 0 |
HNGE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to HNGE. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of 529.27% and a revenue growth 33.58% for HNGE